GES vs GSK · rev $3.00B vs P/E 13, $103.31B cap
Guess? Inc. (GES) versus GlaxoSmithKline PLC ADR (GSK) — a side-by-side from cached financials, not a winner call.
Guess? Inc. (GES) is a apparel retail company listed on US.
GlaxoSmithKline PLC ADR (GSK) is a drug manufacturers - general company listed on US.
Latest reported GES revenue for 2025-02-01 was $3.00B. Net income was $70.8M. Revenue was up 7.9% from 2024-02-03 to 2025-02-01. GES currently screens at market cap $687.7M.
GSK does not have a complete income-statement cache yet.
GES currently screens at market cap $687.7M. GSK currently screens at market cap $103.31B and trailing P/E 13.5.
Not investment advice. Open the GES and GSK stock pages for the full models.
Not investment advice.